Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

AI key to driving precision medicine in cancer?

AI key to driving precision medicine in cancer?

Drinking more than three cups of Italian-style coffee each day lowers prostate cancer risk

Drinking more than three cups of Italian-style coffee each day lowers prostate cancer risk

Study: Prostate cancer patients willing to pay up to $2,000 for new high-tech biopsy technique

Study: Prostate cancer patients willing to pay up to $2,000 for new high-tech biopsy technique

Study highlights need for personalized approaches to prostate cancer screening in high-risk black men

Study highlights need for personalized approaches to prostate cancer screening in high-risk black men

Quality of life for prostate cancer patients varies by type of treatment, study reveals

Quality of life for prostate cancer patients varies by type of treatment, study reveals

Doctors perform first-ever robotic, minimally-invasive surgical removal of stage IV tumor thrombus

Doctors perform first-ever robotic, minimally-invasive surgical removal of stage IV tumor thrombus

Addressing unmet needs in prostate cancer

Addressing unmet needs in prostate cancer

Bacteriophages may help combat antibiotic-resistant 'superbugs'

Bacteriophages may help combat antibiotic-resistant 'superbugs'

Combined treatment regimen shows early promise in eliminating metastatic prostate cancer

Combined treatment regimen shows early promise in eliminating metastatic prostate cancer

Differences found in cancer occurrence within African and US born blacks

Differences found in cancer occurrence within African and US born blacks

U.S. Preventive Services Task Force supports Prostate Cancer Screening in men aged 55–69

U.S. Preventive Services Task Force supports Prostate Cancer Screening in men aged 55–69

High level of protein appears to diminish energy burning power of brown fat

High level of protein appears to diminish energy burning power of brown fat

MIT engineers develop more sensitive approach to reveal ovarian tumors

MIT engineers develop more sensitive approach to reveal ovarian tumors

Clinical study examines impact of yoga on side-effects caused by prostate cancer treatment

Clinical study examines impact of yoga on side-effects caused by prostate cancer treatment

Family history does not appear to increase risk of prostate cancer progression, analysis reveals

Family history does not appear to increase risk of prostate cancer progression, analysis reveals

Protein testing may become potential tool to detect prostate cancer

Protein testing may become potential tool to detect prostate cancer

Number of HIV-positive cancer patients in the U.S. projected to decrease through 2030

Number of HIV-positive cancer patients in the U.S. projected to decrease through 2030

Scientists find new way to detect prostate cancer by 'sniffing' urine

Scientists find new way to detect prostate cancer by 'sniffing' urine

Extreme short and long telomeres linked to increased cancer risk

Extreme short and long telomeres linked to increased cancer risk

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017